Immediate Impact

65 standout
Sub-graph 1 of 20

Citing Papers

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
7 intermediate papers

Works of Lukas Binder being referenced

Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial
2014

Author Peers

Author Last Decade Papers Cites
Lukas Binder 10 17 181 117 61 10 221
Cynthia Knott 24 214 180 35 9 288
Ornella Verrastro 2 36 135 85 46 14 213
K. Huber 4 29 199 105 90 9 276
Jacob George 4 36 219 102 85 14 272
Laura G. Draijer 4 35 205 119 79 14 244
Elmer Schabel 6 23 230 100 119 8 260
G. Jeffrey 3 15 174 99 89 14 288
Yaron Arbel 34 79 174 52 67 8 269
Rie Ibusuki 29 45 106 48 36 13 193
Patricia Ugalde‐Nicalo 21 237 197 36 9 272

All Works

Loading papers...

Rankless by CCL
2026